Uncategorized

Joined at the sensor

This morning Abbott (NYSE: ABT) issued a press release which stated; “Abbott (ABT) today announced that the FreeStyle® Libre System, the company's revolutionary new continuous glucose monitoring (CGM) system, is now available to Medicare patients, having met the codes for therapeutic CGM systems used for coverage by the U.S. Centers for Medicare & Medicaid Services (CMS). Coverage includes all Medicare patients with diabetes who use insulin and who meet the eligibility...

It doesn’t have to make sense

The business of diabetes as we say is a wacky one. Many times companies will do things that just make you sit back scratch your head and wonder just what the heck are they thinking. In the past we used to obese over these things thinking that we must be missing something. That there must be something we don’t know, that even with all the research we do and all...

The Secrecy Squad

We just love it when a report comes out that talks a about some company “secretly” working on a some whiz bang way cool technology. This happens a lot in diabetes given how much the toy makers just love playing with their way cool whiz bang toys. But now that Apple and Amazon have made the deep dive into diabetes these super secret projects have gone to new heights. These...

JPM18 A Preview

It goes without saying that the J P Morgan HealthCare Conference in San Francisco is a great way to start the year. Besides being in that beautiful city by the bay, there is plenty of wackiness going on at the Westin St. Francis. As always the conference will be packed and badges will be commanding a healthy premium on the black market. Just kidding but not a bad idea when...

A Top and a bottom

With Christmas over our attention turns towards a look back at the year gone by and a look ahead to year about to begin. As always, our New Year will begin in that beautiful city by the bay at the JP Morgan Healthcare Conference. A conference which we suspect will be one of the more interesting and since we’ve attended nearly 20 of these suckers that’s saying something. Lots is...

Think this through

Innovation and progress are and always will be critical to improvements in diabetes management. Over the years we have witnessed many innovations which have made life easier for patients with diabetes. It’s unfortunate that over this same time we have not witnessed major improvements in the area that is supposed to count most, outcomes. Yes, there has been some progress in this area but as measured against the millions invested...

Why it’s maddening

We really don’t want to end the year on a rant but what the heck. Diabetic Investor along with many others recently read the results from the Blood Glucose Monitor System (BGMS) Surveillance Program conducted by the Diabetes Technology Society. According to the DTS web site: “The Diabetes Technology Society Blood Glucose Monitor System (BGMS) Surveillance Program was established because of evidence that cleared BGMSs do not always achieve levels of...

What will Santa bring?

As the Christmas holiday approaches one has to wonder what Santa will bring to those of us in the wacky world. Although Santa has not yet reached out to Diabetic Investor to see who’s been naughty and who’s been nice we thought we’d share our gift list for the wacky world. So here goes – For our friends at Tandem (NASDAQ: TNDM) a company that unfortunately falls into the very naughty...

It’s the holiday season

Well it looks as though Christmas has come early for out friends at Bigfoot as they have secured an additional $37 million in funding. This is obviously great news for Bigfoot and not so good news for our friends at Tandem (NASDAQ: TNDM). Think about this just for a moment Bigfoot has a great idea some nice relationships but nothing on the market yet. Tandem has almost 60,000 patients a...

This bus is getting crowded

Yesterday Companion Medical announced the commercial launch of their smart pen the InPen®. Per a company issued press release; “Companion Medical, a leader in the development of advanced technology to improve diabetes care, announced today that it has begun commercial sales of the InPen® system in the United States. InPen is available by prescription only and is a covered benefit under many insurance plans. The InPen is for use with U-100...